Literature DB >> 18036806

The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells.

Amy Erica Lin1, Tak W Mak.   

Abstract

The ubiquitination of proteins by E3 ligases has become an important regulatory mechanism for a variety of immune functions, including the maintenance of self tolerance and suppression of autoreactive T cell development. This review highlights recent advances in our knowledge of the functions in this context of known and potential E3 ligases, including autoimmune regulator (AIRE), TNF receptor-associated factor 6 (TRAF6), Casitas B cell lymphoma b (Cbl-b), gene related to anergy in lymphocytes (GRAIL), Itch, and Roquin. We discuss how disruptions to these molecules may contribute to the loss of T cell homeostasis and the pathogenesis of autoimmunity. We also report on the implications of the potential coordinated actions of these molecules for T cell anergy and regulatory T cell (Treg) functions. The great diversity of E3 ligases and the growing list of cellular processes in which ubiquitination plays a role make for an exciting field of research. Findings emerging from these investigations may suggest ways to exploit the therapeutic potential of manipulating ubiquitination, particularly for autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036806     DOI: 10.1016/j.coi.2007.10.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  38 in total

1.  T-cell signaling and immunopathologies.

Authors:  Christopher E Rudd
Journal:  Semin Immunopathol       Date:  2010-06       Impact factor: 9.623

Review 2.  GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness.

Authors:  Chan C Whiting; Leon L Su; Jack T Lin; C Garrison Fathman
Journal:  FEBS J       Date:  2010-11-16       Impact factor: 5.542

3.  K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation.

Authors:  Mingjin Yang; Taoyong Chen; Xuelian Li; Zhou Yu; Songqing Tang; Chen Wang; Yan Gu; Yanfang Liu; Sheng Xu; Weihua Li; Xuemin Zhang; Jianli Wang; Xuetao Cao
Journal:  Nat Immunol       Date:  2015-09-21       Impact factor: 25.606

4.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.

Authors:  Ingunn M Stromnes; Joseph N Blattman; Xiaoxia Tan; Sara Jeevanjee; Hua Gu; Philip D Greenberg
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

Review 5.  Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.

Authors:  Denise L Gay; Hilda Ramón; Paula M Oliver
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  Expression and SNP association analysis of porcine FBXL4 gene.

Authors:  Y Li; S L Yang; Z L Tang; W T Cui; Y L Mu; M X Chu; S H Zhao; Z F Wu; K Li; K M Peng
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

7.  A role for IL-10 in the transcriptional regulation of Roquin-1.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; John R Klein
Journal:  Gene       Date:  2014-07-23       Impact factor: 3.688

Review 8.  Helminth-derived immunomodulators: can understanding the worm produce the pill?

Authors:  William Harnett; Margaret M Harnett
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

9.  The E3 ligase axotrophin/MARCH-7: protein expression profiling of human tissues reveals links to adult stem cells.

Authors:  Cristina A Szigyarto; Paul Sibbons; Gill Williams; Mathias Uhlen; Su M Metcalfe
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

10.  Enforced expression of roquin protein in T cells exacerbates the incidence and severity of experimental arthritis.

Authors:  Young Rae Ji; Hei Jung Kim; Dong Hoon Yu; Ki Beom Bae; Seo Jin Park; Jun Koo Yi; Nari Kim; Si Jun Park; Keon Bong Oh; Sung Soo Hwang; Sanggyu Lee; Sung-Hyun Kim; Myoung Ok Kim; Jeong Woong Lee; Zae Young Ryoo
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.